In particular, EGFR, MAPK3, and MAPK1 are involved in the HIF-1, estrogen, FoxO, and Rap1 signaling pathways as well as in central carbon metabolism in cancer, prostate cancer, focal adhesion, and gap junction pathways. This evidence concerns the gene MAPK1 and Familial prostate cancer.